In this study, we showed that PIASy silencing prevented I/R-induced loss of membrane Nav1.5, QRS duration increase, elevated arrhythmia scores, VF duration, and episodes of sustained VT and VF. The gene discussed is PIAS4; the disease is cardiac arrhythmia.